Takaoka, Toshi, Kimura, Tetsuo, Shimoyama, Rai, Kawamoto, Shunji, Sakamoto, Kazuki, Goda, Fuminori, Miyamoto, Hiroshi, Negoro, Yuji, Tsuji, Akihito, Yoshizaki, Koji, Goji, Takahiro, Kitamura, Shinji, Yano, Hiromi, Okamoto, Koichi, Kimura, Masako, Okahisa, Toshiya, Muguruma, Naoki, Niitsu, Yoshiro, Takayama, TetsujiSpringer Berlin Heidelberg2016-06-24Cancer Chemotherapy and Pharmacology
国立国会図書館
- 件名colorectal cancer IRIS panitumumab second-line therapy chemother...
- 一般注記...y of IRIS with panitumumab as second-line......ients received panitumumab (6mg/kg) and i......sion IRIS plus panitumumab has an acceptable toxicity pr...
- 並列タイトル等(連結)転移性大腸癌に対する2次治療としてのIRIS+panitumumab療法の有効性の検討 IRIS plus panitumumab for metastatic CRC
Takaoka, Toshi, Kimura, Tetsuo, Shimoyama, Rai, Kawamoto, Shunji, Sakamoto, Kazuki, Goda, Fuminori, Miyamoto, Hiroshi, Negoro, Yuji, Tsuji, Akihito, Yoshizaki, Koji, Goji, Takahiro, Kitamura, Shinji, Yano, Hiromi, Okamoto, Koichi, Kimura, Masako, Okahisa, Toshiya, Muguruma, Naoki, Niitsu, Yoshiro, Takayama, TetsujiSpringer Berlin Heidelberg2016-06-24Cancer Chemotherapy and Pharmacology78 2p.397-403
インターネットで読める全国の図書館
- 件名colorectal cancer IRIS panitumumab second-line therapy chemother...
- 一般注記...y of IRIS with panitumumab as second-line......ients received panitumumab (6mg/kg) and i......sion IRIS plus panitumumab has an acceptable toxicity pr...
- 並列タイトル等(連結)転移性大腸癌に対する2次治療としてのIRIS+panitumumab療法の有効性の検討 IRIS plus panitumumab for metastatic CRC